Elanco Stock Soars 10.14%, Adding $1.2 Billion After Raising Its Full-Year Outlook

Pet-health sales grew, while management expects retail growth even with the existing Costco agreement ending next year.

Share
Elanco Stock Soars 10.14%, Adding $1.2 Billion After Raising Its Full-Year Outlook

Elanco Animal Health, which makes medicines and vaccines for pets and farm animals, soared 10.14% to $26.08 in Friday trading, as of 1:04 PM ET, adding $1.2 billion in market value after lifting its full-year outlook. Stronger pet-health sales included contributions from Zenrelia and Credelio Quattro, while the company's Friday SEC filing set out its raised revenue outlook and higher expectations for adjusted earnings.

Revenue Growth And A Return To Profit

An 11% reported gain put third-quarter revenue at $1.265 billion. Excluding currency movements and changes in business scope, revenue grew 9%.

Elanco earned $18 million in the quarter, compared with a $34 million loss a year earlier. The improved results accompanied the higher full-year forecasts for both revenue and adjusted earnings.

The pet-health business sells treatments for parasites, skin conditions and pain, as well as vaccines for dogs and cats. Its brands include Advantage, Seresto and Credelio. The farm-animal business supplies cattle, poultry, swine and sheep producers with products including feed additives, antibiotics, vaccines and enzymes.

Costco Agreement Ends Next Year

Management said on Friday's earnings call that the existing Costco agreement ends next year. Management nevertheless maintained its expectation that the retail business would grow and that Elanco would have a longer-term relationship with Costco.

Retailers are one part of Elanco's customer base, alongside distributors, veterinarians and farm producers. The company sells products in more than 90 countries under approximately 200 brands; the United States generated 47% of its total revenue in 2025.

A Gain After Trailing The S&P 500

Elanco entered Friday's session behind the broader market. At Thursday's close, the stock was up 5% year-to-date, compared with an 8% gain for the S&P 500 over the same period.

In Friday trading, as of 1:04 PM ET, ELAN shares were on pace for their biggest one-day gain since May 6. Elanco's total market value stood at $13.03 billion in Friday trading, as of 1:04 PM ET.

Sources

More on Elanco Animal Health

All Elanco Animal Health (ELAN) coverage →